| ADVANCED ENZYME TECHNOLOGIES  | 
The Current P/S Ratio of ADVANCED ENZYME TECHNOLOGIES  is 5.21.
                
| Share Price | ₹311.4 | Oct 30,2025 | 
| Market Cap | ₹3,484.6 Cr | |
| Sales-TTM | ₹668.3 Cr | TTM-Consolidated Results | 
| Price/Sales | 5.21x | Calculated as Market Cap/Sales | 
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ADVANCED ENZYME TECHNOLOGIES
                    P/S = 
                    Market Capitalization  
                    /
                    Sales
                    
                    or, using per-share numbers:
                    
                    P/S = Stock Price / Sales Per Share
                
                Current Market Cap [ ₹3,484.6 Cr] as on Oct 30,2025                
                                    (/) Sales [ ₹668.3 Cr] based on TTM-Consolidated Results
                                    
                
                (=) P/S Ratio [ 5.21x ]
            
Thus, for ADVANCED ENZYME TECHNOLOGIES , the investors are currently willing to pay '5.21 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ADVANCED ENZYME TECHNOLOGIES !
The chart below summarizes the trend in P/S Ratio of ADVANCED ENZYME TECHNOLOGIES over the last five years.
Historical PS (Price/Sales) ratio chart of ADVANCED ENZYME TECHNOLOGIES
PS Ratio Performance Analysis for ADVANCED ENZYME TECHNOLOGIES
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 5.91x.
- ADVANCED ENZYME TECHNOLOGIES 's operated at median p/e ratio of 5.96x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ADVANCED ENZYME TECHNOLOGIES 's p/e ratio peaked in Mar2021 at 7.68x.
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio hit its five-year low in Mar2023 of 4.79x.
How does ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) | 
|---|---|---|---|
| ADVANCED ENZYME TECHNOLOGIES | 668.3 | 5.21 | 3,484.6 | 
| SUN PHARMACEUTICAL INDUSTRIES LTD | 53,777.1 | 7.60 | 408,751.0 | 
| DIVIS LABORATORIES LTD | 9,652.0 | 18.30 | 176,634.0 | 
| CIPLA LTD | 28,349.6 | 4.39 | 124,437.0 | 
| TORRENT PHARMACEUTICALS LTD | 11,835.0 | 10.30 | 121,871.0 | 
| DR REDDYS LABORATORIES LTD | 34,310.0 | 2.92 | 100,333.0 | 
| MANKIND PHARMA LTD | 12,956.2 | 7.79 | 100,950.0 | 
| ZYDUS LIFESCIENCES LTD | 23,607.7 | 4.20 | 99,244.9 | 
| LUPIN LTD | 23,375.9 | 3.80 | 88,847.7 | 
| AUROBINDO PHARMA LTD | 32,024.8 | 2.00 | 64,033.4 | 
| ABBOTT INDIA LTD | 6,589.9 | 9.56 | 62,972.6 | 
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio | 
|---|---|
| Min industry PS | 2.00x | 
| Max industry PS | 18.30x | 
| Median industry PS | 5.21x | 
| Average industry PS | 6.92x | 
You may also like the below Video Courses
 
                                     
                                     
                                    